Arnar Masson is an independent advisor and Board member. Masson is currently on the Board of Directors of Siminn, which is the largest telecom company in Iceland and listed on Nasdaq Iceland. He also serves on the Remuneration Committee at Siminn and is a Board member of Festa – Center for Sustainability in Iceland. 

Masson was Chief Human Resources and Strategy Officer at Isavia, a company that handles the operations and development of all airports in Iceland. Prior to that he was an alternate director at the European Bank for Reconstruction and Development (EBRD) in London, an investment and development bank that works primarily with private sector clients in developing economies. 

Before joining EBRD Masson worked in the Government Offices in Iceland, first as Deputy Director General in the Ministry of Finance and later as a Director-General in the Prime Minister’s Office in Iceland. From 2000 to 2008 Masson held an adjunct lecturer position at the Department of Political Science of the University of Iceland. 

Masson has experience in strategy development and implementation, human resources, ESG, M&A, political affairs, and has worked with emerging markets. He has done executive courses for board directors both at Harvard Business School in the US and IMD in Switzerland. 

He has no interest links with the company’s main customers, competitors, or major shareholders.

EDUCATION MSc, Comparative Politics, London School of Economics and Political Science  BA, Political Science, University of Iceland 

ELECTED 2021 Chairman  2013 Vice-Chairman  2001 Board Director 

SUB-COMMITTEES Remuneration Committee (Chair) Nomination Committee

HOLDINGS IN MAREL 0 shares

Dr. Olafur Gudmundsson is currently the Head of Discovery Pharmaceutics and Analytical Sciences at Bristol-Myers Squibb (BMS), a global biopharmaceutical company. For more than two decades, Gudmundsson has held roles of increasing responsibility within research and development, covering multiple therapeutic areas and stages of drug discovery, both for Bristol-Myers Squibb and Genentech. During his tenure at BMS, Gudmundsson has helped bring multiple drug candidates to clinical trials, several of which have become marketed products.  

In his time within the pharmaceutical industry, Gudmundsson’s responsibilities have included involvement with global portfolio strategy, evaluation of external acquisitions, strategic innovations, and integration of merged companies. Gudmundsson has participated in governance teams providing input on global portfolio optimization and prioritization, and has led process optimization teams and chaired integration teams. 

Gudmundsson is also associated with the graduate program of the Pharmaceutical Chemistry department at Purdue University. Currently, Gudmundsson is a Board member of Eyrir Invest and Noruz. 

He has no interest links with the company’s main customers.

EDUCATION PhD, Pharmaceutical Chemistry, University of Kansas  Cand. Pharm., Pharmacy, University of Iceland 

ELECTED 2021 Vice-Chairman  2014 Board Director 

SUB-COMMITTEES Remuneration Committee Nomination Committee

HOLDINGS IN MAREL 1,705,427 shares

Ann Savage is an advisor to Gousto, a UK meal kit manufacturer and retailer. Savage worked for Gousto from 2018 to 2022 in an advisory role and headed the Food Technical function. Savage previously served as Group Technical Director of Bakkavor. Her primary responsibilities have included food safety, health and safety management, manufacturing excellence, and corporate social responsibility management in the UK, US, and Asia.  

Savage has held a variety of roles in technical and research and development departments within the retail and food industry over her 40-year career. She worked for the Cooperative Wholesale Society (CWS), Northern Foods from 1990 until 1999, and at Geest/Bakkavor for more than 19 years. 

Savage’s responsibilities have included representing businesses with UK regulators such as the Food Standards Agency, the Department for Environment Food and Rural Affairs, and Health Protection England. She has chaired the Food Network for Ethical Trade and the IGD Technical Leadership Forum and has been a member of the advisory group for the Better Regulation Task Force and the British Retail Consortium Advisory Board. Savage has worked closely with UK retailers to deliver on their corporate social responsibility commitments and to develop reporting procedures. 

She has experience in operational management, product development, and incident management. She has worked with Farm Africa in both Tanzania and Kenya to support African endeavors in tilapia fish farming and beekeeping. She is a member of her parish council and a Governor of Boston College, one of the top five colleges in the UK. 

She has no interest links with the company’s main customers, competitors, or major shareholders.

EDUCATION Mathematics, Technology and Systems Management, Open University Postgraduate Diploma in Management Studies, Nottingham University

ELECTED 2013 Board Director

SUB-COMMITTEES Audit Committee

HOLDINGS IN MAREL 0 shares

Astvaldur Johannsson is Business Development Director at Controlant, a global real-time monitoring software solution (IoT) provider focusing on the pharmaceutical industry.  

His previous international business experience includes senior management positions within different markets at Össur hf., a global medical devices manufacturer, and as an Executive Director leading the international division of Valitor hf., an eCommerce payment solutions and services provider. Previously Johannsson also served as a member of the Executive Team of the IT company Nyherji hf., as a Sales and Marketing Director at Penninn, and as a system analyst expert in the IT sector focusing on process design and development. 

Johannsson is a proactive professional with extensive international experience of leadership within different marketplaces in the EU, US and Asia, and cross-functional environments, both on the executive and on a board level. He has a comprehensive background and knowledge in formulating and implementing policy and strategy, leading and integrating new businesses and initiatives to improve business performance.  

Johannsson has a solid background in managing business-to-business and business-to-consumer sales and marketing, business development, supply chain, outsourcing, negotiating contracts, and product management, along with operations knowledge and experience in varying industries with progressive and successful organizations. 

He has no interest links with the company’s main customers, competitors, or major shareholders. 

EDUCATION MBA, University of Iceland BSc, Management Information Systems, Heriot-Watt University

ELECTED 2014 Board Director

SUB-COMMITTEES Audit Committee

HOLDINGS IN MAREL 0 shares

Lillie Li Valeur is a member of the Board of Directors, Remuneration Committee, and Science and Innovation Committee of Chr. Hansen Holding, a global bioscience company listed on Nasdaq Copenhagen.

Valeur has extensive international experience in the food, ingredients, and pharmaceutical industries, with special focus on EMEA, Asia, emerging markets, commercial leadership, innovation, mergers and acquisitions, and strategic partnerships. Valeur has served as CEO for COCIO A/S in Denmark.  

During her 18 years with Arla Foods amba, a leading global dairy company, Valeur held several senior management roles, both in Asia and globally, including VP Greater China, VP South East Asia, and VP Global Milk Based Beverages. Prior to that she held various international business management positions at Lundbeck in Denmark, Novartis Consumer Health Co. in Shanghai, as well as a management consulting position at Bain & Company in Beijing. 

From 2013 to 2020 Valeur was a member of the Board of Directors and Audit Committee of AAK, a global Sweden-based plant-based oils and fats company that is listed on Nasdaq Stockholm. From 2015 to 2016 she was a member of the Board of Directors of Meda, a European Swedish-based specialty pharmaceutical company. 

She has no interest links with the company’s main customers, competitors, or major shareholders. 

EDUCATION MBA, China European International Business School Degree in Medicine, Shanghai Medical University

ELECTED 2020 Board Director

SUB-COMMITTEES Nomination Committee  Remuneration Committee 

HOLDINGS IN MAREL 0 shares

Dr. Svafa Grönfeldt is a Professor of Practice at the Massachusetts Institute of Technology. She is a founding member of MIT’s newest innovation accelerator DesignX, focused on the design and development of technology- and service-based ventures created at MIT. Grönfeldt is the co-founder of The MET fund, a Cambridge based seed investment fund. She is also the Vice-Chairman of the Board of Directors of Össur, a global leader in orthopedic solutions since 2008, and member of the Board of Directors of Icelandair since 2019, where she is a member of the Audit Committee and the Strategy Committee. 

Grönfeldt’s previous positions include executive leadership positions at two global life science companies, where she served as Chief Organizational and Development Officer of Alvogen and Deputy to the CEO of Actavis Group. For more than 20 years, her executive career has been focused on organizational design for high growth companies, strategy implementation, service process design, and performance tracking as well as the integration of acquired companies and new business units. She is a former President of Reykjavik University. 

She has no interest links with the company’s main customers, competitors, or major shareholders. 

EDUCATION PhD, London School of Economics and Political Science  MSc, Technical and Professional Communication from Florida Institute of Technology 

ELECTED 2021 Board Director

SUB-COMMITTEES Audit Committee (Chairwoman)

HOLDINGS IN MAREL 0 shares

Ton van der Laanis a Dutch national residing in the Netherlands. He currently serves as Chairman of the Supervisory Board of Royal de Heus, a global feed company, and Vice-Chairman of the Board of Directors of Rainforest Alliance in New York. He is a non-executive Board member of Dümmen Orange. 

Van der Laan has extensive experience from several executive roles in the food, feed, and commodity industries. He is the former CEO of Nidera, a company globally active in financing and distribution of grains and oilseeds. Before that he was responsible as Executive Vice President for Cargill Animal Proteins and Animal Nutrition globally and CEO of Provimi in the Netherlands, one of the global leaders in animal nutrition. 

Previously, for more than 22 years, Van der Laan held several executive roles at Unilever, the Anglo-Dutch consumer food company, where he was located in the Netherlands, UK, Czech Republic, and Slovakia. He has also served as the Managing Director of Philips Domestic Appliances and Personal Care. Van der Laan possesses extensive experience in multinational businesses, strategic planning, portfolio management, acquisitions and company restructuring, large and small scale integrations, and top team development. 

He has no interest links with the company’s main customers, competitors, or major shareholders. 

EDUCATION MSc, Mechanical Engineering, University of Twente  New Board Program, Nyenrode Business University 

ELECTED 2019 Board Director

SUB-COMMITTEES Audit Committee

HOLDINGS IN MAREL 0 shares